Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
J Fernando, P Sancho… - Journal of cellular …, 2012 - Wiley Online Library
Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
[PDF][PDF] SORAFENIB SENSITIZES HEPATOCELLULAR CARCINOMA CELLS TO PHYSIOLOGICAL APOPTOTIC STIMULI
J Fernando, P Sancho, CM Fernández-Rodriguez… - J Cell Physiol, 2012 - academia.edu
Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
J Fernando, P Sancho… - Journal of Cellular …, 2012 - infona.pl
Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
J Fernando, P Sancho… - Journal of Cellular …, 2012 - diposit.ub.edu
Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.
J Fernando, P Sancho… - Journal of Cellular …, 2012 - diva-portal.org
Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
[PDF][PDF] SORAFENIB SENSITIZES HEPATOCELLULAR CARCINOMA CELLS TO PHYSIOLOGICAL APOPTOTIC STIMULI
J Fernando, P Sancho, CM Fernández-Rodriguez… - J Cell …, 2012 - researchgate.net
Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
J Fernando, P Sancho… - Journal of Cellular …, 2012 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Sorafenib increases survival rate of patients
with advanced hepatocellular carcinoma (HCC). The mechanism underlying this effect is not …
with advanced hepatocellular carcinoma (HCC). The mechanism underlying this effect is not …
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli.
J Fernando, P Sancho… - Journal of Cellular …, 2012 - europepmc.org
Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
J Fernando, P Sancho… - Journal of cellular …, 2012 - pubmed.ncbi.nlm.nih.gov
Sorafenib increases survival rate of patients with advanced hepatocellular carcinoma
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
(HCC). The mechanism underlying this effect is not completely understood. In this work we …
[引用][C] Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli
J Fernando, P Sancho… - Journal of Cellular …, 2012 - produccioncientifica.ucm.es